Tolerability and discontinuation rates in teriflunomide-treated patients: A real-world clinical experience

OBJECTIVES: To assess the real-world tolerability of teriflunomide in multiple sclerosis (MS) patients from a large Canadian MS Centre of Care to determine whether previously treated (PT) patients have different tolerability thresholds than treatment-naive (TN) patients, leading to differing discont...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurosciences (Riyadh)
Hauptverfasser: Alnajashi, Hind A., Alshamrani, Foziah J., Freedman, Mark S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Riyadh : Armed Forces Hospital 2018
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8015587/
https://ncbi.nlm.nih.gov/pubmed/30007995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17712/nsj.2018.3.20180003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge